Back
Apellis Pharmaceuticals Vs. EyePoint Pharmaceuticals Industry Stock Comparison
Sell
42
APLS
Apellis Pharmaceuticals
Last Price:
26.36
Seasonality Move:
20.78%
Buy
69
EYPT
EyePoint Pharmaceuticals
Last Price:
10.06
Seasonality Move:
27.28%
Sell
42
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $28.06. The Score for APLS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
EyePoint Pharmaceuticals (EYPT)
is a Buy
Is EyePoint Pharmaceuticals a Buy, Sell or Hold?
- The current EyePoint Pharmaceuticals [EYPT] share price is $10.49. The Score for EYPT is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
- EYPT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $28.06
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.
EYPT Stock Price Chart
What is EyePoint Pharmaceuticals's stock price today?
-
The EyePoint Pharmaceuticals share price today is $10.49
The current trend is moderately bearish and EYPT is experiencing slight selling pressure.
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 45.18 | Sell |
| Chaikin Money Flow: | -2912738 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.06 - 28.78) | Buy |
| Bollinger Bands (100): | (29.25 - 39.19) | Sell |
EYPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.44 | Buy |
| Relative Strength Index (14 RSI): | 47.57 | Sell |
| Chaikin Money Flow: | -153416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.83 - 11.91) | Sell |
| Bollinger Bands (100): | (8.07 - 10.47) | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.85 | Sell |
| 20-day SMA: | 28.04 | Buy |
| 50-day SMA: | 30.45 | Sell |
| 200-day SMA: | 43.48 | Sell |
| 8-day EMA: | 28.61 | Sell |
| 20-day EMA: | 28.52 | Sell |
| 50-day EMA: | 30.4 | Sell |
| 200-day EMA: | 40.17 | Sell |
EYPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.41 | Sell |
| 20-day SMA: | 11.17 | Sell |
| 50-day SMA: | 9.65 | Buy |
| 200-day SMA: | 14.13 | Sell |
| 8-day EMA: | 11.18 | Sell |
| 20-day EMA: | 10.96 | Sell |
| 50-day EMA: | 10.2 | Buy |
| 200-day EMA: | 11.62 | Sell |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.75 per share, and an increase next year of $0.83 per share.
EyePoint Pharmaceuticals Earnings Growth & EYPT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.36 per share.
Apellis Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
EyePoint Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||